US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ETHZilla Corporation

2.81

-0.0600-2.09%

Post-market: 2.840.0301+1.07%19:59 EDT

Volume:11.34M

Turnover:31.19M

Market Cap:465.00M

PE:-0.18

High:2.90

Open:2.87

Low:2.65

Close:2.87

52wk High:17.75

52wk Low:0.6578

Shares:165.48M

Float Shares:151.00M

Volume Ratio:0.38

T/O Rate:7.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-15.4906

EPS(LYR):-15.4906

ROE:-371.02%

ROA:-55.46%

PB:86.42

PE(LYR):-0.18

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ETHZilla Corporation

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

4

Office Location:

2875 South Ocean Blvd,Suite 200,Palm Beach,Florida,United States

Website:

http://www.180lifesciences.com

Zip Code:

33480

Phone:

Fax:

- -

Introduction:

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

Directors

Name

Position

Blair Jordan

Chief Executive Officer and Director

McAndrew Rudisill

Executive Chairman

Ryan L. Smith

Lead Independent Director

Stephen H. Shoemaker

Independent Director

Andrew Suckling

Director

Crystal Heter

Director

Jason New

Director

Shareholders

Name

Position

Blair Jordan

Chief Executive Officer and Director

Eric R. Van Lent

Chief Accounting Officer and Principal Financial Officer

McAndrew Rudisill

Executive Chairman

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ETHZ/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ETHZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETHZ\",,,,,undefined,":{"symbol":"ETHZ","market":"US","secType":"STK","nameCN":"ETHZilla Corporation","latestPrice":2.81,"timestamp":1756497600000,"preClose":2.87,"halted":0,"volume":11339780,"hourTrading":{"tag":"盘后","latestPrice":2.8401,"preClose":2.81,"latestTime":"19:59 EDT","volume":379550,"amount":1069081.6826,"timestamp":1756511977029},"delay":0,"floatShares":151000000,"shares":165478655,"eps":-15.490594,"marketStatus":"Market Closed","change":-0.06,"latestTime":"08-29 16:00:00 EDT","open":2.87,"high":2.9,"low":2.65,"amount":31194328.64728,"amplitude":0.087108,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.490594,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.87,"preHourTrading":{"tag":"盘前","latestPrice":2.8999,"preClose":2.87,"latestTime":"09:29 EDT","volume":318490,"amount":916549.8850199999,"timestamp":1756474181997},"postHourTrading":{"tag":"盘后","latestPrice":2.8401,"preClose":2.81,"latestTime":"19:59 EDT","volume":379550,"amount":1069081.6826,"timestamp":1756511977029},"volumeRatio":0.38478184214024,"impliedVol":0.9872,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ETHZ\",,,,,undefined,":{"symbol":"ETHZ","floatShares":151000000,"roa":"-55.46%","roe":"-371.02%","lyrEps":-15.490594,"volumeRatio":0.38478184214024,"shares":165478655,"dividePrice":0,"high":2.9,"amplitude":0.087108,"preClose":2.87,"low":2.65,"week52Low":0.6578,"pbRate":"86.42","week52High":17.75,"institutionHeld":0,"latestPrice":2.81,"eps":-15.490594,"divideRate":0,"volume":11339780,"delay":0,"ttmEps":-15.490594,"open":2.87,"prevYearClose":1.82,"prevWeekClose":3.3,"prevMonthClose":3.28,"prevQuarterClose":0.9282,"fiveDayClose":3.3,"twentyDayClose":3.54,"sixtyDayClose":1.0692},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ETHZ\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ETHZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ETHZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ETHZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ETHZ","date":"2025-08-29","current":-51.588221,"percent":1,"low":-123.981267,"twenty":-99.620035,"median":-58.947783,"eighty":-55.251403,"high":-51.588221,"avg":-76.340864,"sd":26.546732,"marketCap":474923739},"quantilePoints":[{"date":"2025-08-22","current":-80.479068,"twenty":-120.266848,"median":-102.648458,"eighty":-84.695435,"marketCap":740894324},{"date":"2025-08-29","current":-51.588221,"twenty":-99.620035,"median":-58.947783,"eighty":-55.251403,"marketCap":474923739}],"updateTime":1756554197598},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":587644367,"employeeNum":4,"address":"2875 South Ocean Blvd,Suite 200,Palm Beach,Florida,United States","zipCode":"33480","officePhone":"650 507 0669"},"stockCompanyDetail":{"websiteUrl":"http://www.180lifesciences.com","stockEarnings":[{"period":"1week","weight":-0.4033},{"period":"1month","weight":-0.1087},{"period":"3month","weight":1.8},{"period":"6month","weight":1.453},{"period":"1year","weight":0.4794},{"period":"ytd","weight":0.5769}],"compareEarnings":[{"period":"1week","weight":0.021},{"period":"1month","weight":0.0215},{"period":"3month","weight":0.101},{"period":"6month","weight":0.0921},{"period":"1year","weight":0.1623},{"period":"ytd","weight":0.1072}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.032089},{"month":2,"riseRate":0.5,"avgChangeRate":-0.000209},{"month":3,"riseRate":0.25,"avgChangeRate":-0.079985},{"month":4,"riseRate":0.375,"avgChangeRate":-0.020557},{"month":5,"riseRate":0.5,"avgChangeRate":-0.054077},{"month":6,"riseRate":0.75,"avgChangeRate":-0.042052},{"month":7,"riseRate":0.666667,"avgChangeRate":0.295972},{"month":8,"riseRate":0,"avgChangeRate":-0.111844},{"month":9,"riseRate":0.5,"avgChangeRate":-0.055536},{"month":10,"riseRate":0.25,"avgChangeRate":0.086691},{"month":11,"riseRate":0.25,"avgChangeRate":-0.175583},{"month":12,"riseRate":0.375,"avgChangeRate":-0.169849}],"exchange":"NASDAQ","name":"ETHZilla Corporation","nameEN":"ETHZilla Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ETHZ\",market:\"US\",,,undefined,":{"directors":[{"name":"Blair Jordan","position":"Chief Executive Officer and Director"},{"name":"McAndrew Rudisill","position":"Executive Chairman"},{"name":"Ryan L. Smith","position":"Lead Independent Director"},{"name":"Stephen H. Shoemaker","position":"Independent Director"},{"name":"Andrew Suckling","position":"Director"},{"name":"Crystal Heter","position":"Director"},{"name":"Jason New","position":"Director"}],"executives":[{"name":"Blair Jordan","position":"Chief Executive Officer and Director"},{"name":"Eric R. Van Lent","position":"Chief Accounting Officer and Principal Financial Officer"},{"name":"McAndrew Rudisill","position":"Executive Chairman"}]}}}